Coreg and Hyperparathyroidism secondary - a phase IV clinical study of FDA data
Summary:
Hyperparathyroidism secondary is reported as a side effect among people who take Coreg (carvedilol), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Nexium, and have Gastroesophageal reflux disease.
The phase IV clinical study analyzes which people have Hyperparathyroidism secondary when taking Coreg. It is created by eHealthMe based on reports of 48,155 people who have side effects when taking Coreg from the FDA, and is updated regularly.
What is Coreg?
Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,584 Coreg users. Check the latest studies of Coreg.
What is Hyperparathyroidism secondary?
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary) is found to be associated with 698 drugs and 462 conditions by eHealthMe. Check the latest studies of Hyperparathyroidism secondary.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
48,155 people reported to have side effects when taking Coreg.
Among them, 168 people (0.35%) have Hyperparathyroidism secondary.
Among these 168 people:
How long have people been on Coreg when they have Hyperparathyroidism secondary? *
What is the gender of people who have Hyperparathyroidism secondary when taking Coreg? *
What is the age of people who have Hyperparathyroidism secondary when taking Coreg? *
What are other drugs people take besides Coreg? *
What are other side effects people have besides Hyperparathyroidism secondary? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Coreg and have Hyperparathyroidism secondary?
- Check whether Hyperparathyroidism secondary is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Coreg:
- Coreg (49,584 reports)
Hyperparathyroidism secondary treatments and more:
- Hyperparathyroidism secondary (29,891 reports)
How severe was Hyperparathyroidism secondary and when was it recovered:
Expand to all the drugs that have ingredients of carvedilol:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Coreg:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hyperparathyroidism secondary:
- Hyperparathyroidism secondary (698 drugs)
Browse all the conditions that are associated with Hyperparathyroidism secondary:
- Hyperparathyroidism secondary (462 conditions)
Related publications that referenced our studies
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on carvedilol (the active ingredients of Coreg) and Coreg (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cometriq cause Hypertension Aggravated? - 9 seconds ago
- Could Remicade cause Breast Cancer Aggravated? - 9 seconds ago
- Could Hygroton cause Agranulocytosis? - 26 seconds ago
- Could Hydroxyurea cause Splenomegaly? - 28 seconds ago
- Enzalutamide and Appetite Decreased for Men aged 60+ - 29 seconds ago
- Enzalutamide and Reduced Appetite for Men aged 60+ - 30 seconds ago
- Enzalutamide and Loss Of Appetite for Men aged 60+ - 30 seconds ago
- Enzalutamide and Decreased Appetite for Men aged 60+ - 30 seconds ago
- Enzalutamide and Appetite - Decreased for Men aged 60+ - 31 seconds ago
- Could Colestid cause Confusional State? - 44 seconds ago